Philadelphia, PA, United States of America

Mathilde Bouché

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mathilde Bouché: Innovator in Hydrogel Technology

Introduction

Mathilde Bouché is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative hydrogels for therapeutic applications. Her work focuses on enhancing the effectiveness of cancer treatments through advanced materials.

Latest Patents

Mathilde Bouché holds a patent for a groundbreaking invention titled 'Smart' hydrogel for the radiosensitization and sustained delivery of therapeutics triggered by irradiation. This invention comprises a biodegradable polyphosphazene polymer, a radiation-sensitive diselenide cross-linker, and one or more payloads releasably loaded within the hydrogel. The hydrogel is designed to radiosensitize target tissues, such as tumors, and provide sustained delivery of therapeutics when triggered by irradiation. The method involves introducing the hydrogel adjacent to malignant or marginal tissue and administering radiation to disrupt the cross-linkers, thereby releasing the payloads.

Career Highlights

Mathilde Bouché is affiliated with the University of Pennsylvania, where she conducts her research and development work. Her innovative approach to hydrogel technology has positioned her as a key figure in the field of cancer therapeutics.

Collaborations

She collaborates with notable colleagues, including Jay Dorsey and Saad Sheikh, who contribute to her research endeavors and help advance her innovative projects.

Conclusion

Mathilde Bouché's contributions to hydrogel technology represent a significant advancement in the field of cancer treatment. Her innovative work continues to pave the way for new therapeutic strategies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…